Fulgent Genetics
FLGT
16 hedge funds and large institutions have $6.01M invested in Fulgent Genetics in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 4 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
4% more capital invested
Capital invested by funds: $5.79M → $6.01M (+$224K)
0.01% more ownership
Funds ownership: 8.11% → 8.12% (+0.01%)
20% less funds holding
Funds holding: 20 → 16 (-4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$136K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$125K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$34.7K |
| 4 |
OWIM
Old West Investment Management
Los Angeles,
California
|
+$25.8K |
| 5 |
RA
Royce & Associates
New York
|
+$17.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MA
Mutual Advisors
Omaha,
Nebraska
|
-$308K |
| 2 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$9.7K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6K |
| 4 |
BlackRock
New York
|
-$2.38K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$2K |
FLGT Hedge Fund Activity: Q2 2018 in Review
16 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q2 2018, worth a combined $6.01M — up 3.9% from $5.79M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of FLGT and 0 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 7 added.
The largest buyer was Granahan Investment Management, adding an estimated $136K. The largest seller was Mutual Advisors, cutting an estimated $308K.
- 16 institutional investors held Fulgent Genetics (FLGT) as of Q2 2018, down from 20 in Q1 2018.
- Funds reported $6.01M of Fulgent Genetics stock for Q2 2018, up 3.9% quarter-over-quarter.
- 0 funds opened new Fulgent Genetics positions in Q2 2018 and 4 closed out, a net change of -4 holders.
- The largest Fulgent Genetics buyer in Q2 2018 was Granahan Investment Management, an estimated $136K added.
- The largest Fulgent Genetics seller in Q2 2018 was Mutual Advisors, an estimated $308K sold.
Based on aggregated 13F filings for Q2 2018.